Skip to content

medical device clinical trial to evaluate the safety and efficacy of BAMK-M100 to help treat constipation in patients with chronic constipation

medical device clinical trial to evaluate the safety and efficacy of BAMK-M100 to help treat constipation in patients with chronic constipation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0006315
Enrollment
15
Registered
2021-07-02
Start date
2020-04-22
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Model : BAMK-M100 The air cell is installed in the inner space of the curved frame and receives air from the pump through supply lines. The device manipulates the patient’s abdominal

Sponsors

BMS
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) age 20–80 years, 2) body mass index 18–40 kg/m2, 3) constipation symptom profile according to the April 2016 Rome IV guidelines, and 4) agreement to participate in this study. CC was defined as constipation with long-term symptom duration (onset = 6 months previously and currently symptomatic for =3 months) and the presence of more than two self-reported symptom clusters (hard stools, straining, sensation of incomplete evacuation, sensation of anorectal obstruction, need for manual maneuvers to facilitate >25% defecation, and fewer than three spontaneous bowel movements per week).

Exclusion criteria

Exclusion criteria: 1) diagnosis by abnormal colonoscopy or abdominal imaging findings within 2 years; 2) constipation related to a previous surgery or other organic disorder, including Parkinson’s disease and paraplegic disorders (stroke, spinal disorders, multiple sclerosis, and hypothyroidism,); 3) history of open abdominal surgery or peritonitis; 4) history of gastric or small bowel surgery; 5) history of gall bladder surgery; 6) cardiovascular, pulmonary, or other endocrinological disorder that might affect study enrollment; and 7) pregnancy or breastfeeding status.

Design outcomes

Primary

MeasureTime frame
Colon Transit Time

Countries

Korea, Republic of

Contacts

Public ContactSungwon Yoon

BMS

bms0944@naver.com+82-31-901-0944

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026